
Longsee provides R&D and data-driven technologies to optimize the gut microbiome in clinical care. It develops IVD reagents and equipment, whole intestinal flora microbiota transplantation, living biological medicines, and AI-enabled medical services. Target customers include clinical laboratories, healthcare providers, and research partners. The company operates in the clinical diagnostics and high-end health management segments.

Longsee provides R&D and data-driven technologies to optimize the gut microbiome in clinical care. It develops IVD reagents and equipment, whole intestinal flora microbiota transplantation, living biological medicines, and AI-enabled medical services. Target customers include clinical laboratories, healthcare providers, and research partners. The company operates in the clinical diagnostics and high-end health management segments.